Vani Simmons named assistant center director of Moffitt’s Office of Community Outreach, Engagement, and Equity

TAMP procedure shows 52% reduction in pancreatic tumor metabolic activity, Moffitt case study shows

Researchers at Moffitt Cancer Center have published a case study highlighting the potential optimization of the TAMP, or trans-arterial micro-perfusion, procedure with RenovoCath to deliver intra-arterial gemcitabine (a commonly used chemotherapy) directly near a tumor (rather than traditional systemic IV administration) in a patient with locally advanced pancreatic cancer.

June 26, 2026

Vol.52 No.25

Clinical Roundup

DYV800 topical therapy targets tumor acidity, preclinical study finds

A novel transdermal therapy designed to modulate tumor pH called DYV800 helped make tumors substantially less acidic, restore T-cell activity, slow tumor growth, and improve survival in preclinical studies, according to a study using animal models of bladder cancer conducted by Dyve Biosciences, in collaboration with Moffitt Cancer Center.

April 17, 2026

Vol.52 No.15

In Brief

Moffitt receives $22.4M grant to advance research and clinical trials for leptomeningeal disease

Researchers at Moffitt Cancer Center have been awarded a $22.4 million grant from the U.S. Department of War to lead studies and clinical trials for leptomeningeal disease, a devastating complication of breast and other cancers that spreads to the coverings of the brain and spinal cord.

October 10, 2025

Vol.51 No.37

In Brief

Moffitt and Mainsail collaborate to bring $84M full-service hotel to Tampa

Moffitt Cancer Center and Tampa-based Mainsail Lodging & Development announced a partnership to bring a new 200-room, full-service hotel to Moffitt’s McKinley Campus. Expected to open in summer 2028, the hotel aims to enhance the experience of patients, families, visiting physicians and scientists, and the broader community.

September 26, 2025

Vol.51 No.35

In Brief

UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research

The U.S. Department of Defense Prostate Cancer Research Program has awarded the Data Science Award and a $1.2 million grant to researchers Charles Gaber, Natalie Reizine, Todd Lee, Lucia Petito, and Jessica Islam.

August 01, 2025

Vol.51 No.30

Clinical Trials & Tribulations

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers.

June 27, 2025

Vol.51 No.25

By Ghulam Rasool, Brian D. Gonzalez and Katherine Chung-Bridges

Vani Simmons named assistant center director of Moffitt’s Office of Community Outreach, Engagement, and Equity

YOU MAY BE INTERESTED IN

TAMP procedure shows 52% reduction in pancreatic tumor metabolic activity, Moffitt case study shows

DYV800 topical therapy targets tumor acidity, preclinical study finds

Moffitt receives $22.4M grant to advance research and clinical trials for leptomeningeal disease

Moffitt and Mainsail collaborate to bring $84M full-service hotel to Tampa

UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Renew today!

Subscriber content

Never miss an issue!

Login